Effectiveness of Omicron XBB.1.5 vaccine against infection with SARS-CoV-2 Omicron XBB and JN.1 variants, prospective cohort study, the Netherlands, October 2023 to January 2024.
Huiberts, Anne J Hoeve, Christina E de Gier, Brechje Cremer, Jeroen van der Veer, Bas de Melker, Hester E van de Wijgert, Janneke Hhm van den Hof, Susan Eggink, Dirk Knol, Mirjam J
Huiberts, Anne J
Hoeve, Christina E
de Gier, Brechje
Cremer, Jeroen
van der Veer, Bas
de Melker, Hester E
van de Wijgert, Janneke Hhm
van den Hof, Susan
Eggink, Dirk
Knol, Mirjam J
Citations
Altmetric:
Series / Report no.
Open Access
Type
Article
Language
en
Date of publication
2024-03-11
Year of publication
Research Projects
Organizational Units
Journal Issue
Title
Effectiveness of Omicron XBB.1.5 vaccine against infection with SARS-CoV-2 Omicron XBB and JN.1 variants, prospective cohort study, the Netherlands, October 2023 to January 2024.
Translated Title
Published in
Euro Surveill 2024;29(10):pii.2400109